The Circuit Notify me• Jun 3, 2026• 31:21Interview

The Rise, Bankruptcy and Rebirth of 23andMe | The Circuit

From The Circuit

Emily Chang(Host)•Ann Wojcicki(Co-founder and CEO, 23andMe)•Anne Wojcicki(Guest)•Esther Wojcicki(Panelist)•Kristin V. Brown(Panelist)

Get the full transcript next time The Circuit releases an episode

Summary, key quotes, top claims, and the searchable transcript - emailed automatically. No card needed.

Executive Summary

Continue your research

Keep pulling the thread on Ann Wojcicki.

The Rise and Fall of a Biotech Darling Founder's Resilience and Comeback

12 quotes

Concerns Raised

Market saturation for direct-to-consumer DNA test kits, as most early adopters have already purchased one.
The financial viability of the new nonprofit model, which relies on continued kit sales and donations to fund ambitious research goals.
Rebuilding consumer trust and navigating privacy concerns following the highly publicized security incident.
The fundamental scientific challenge that most common diseases are genetically complex, making the initial promise of 'designer drugs' difficult to realize.

Opportunities Identified

Leveraging the existing 13 million-person recontactable database for AI-driven research and drug discovery.
Tapping into growing consumer interest in preventative health and skepticism of the traditional healthcare system.
Attracting mission-aligned philanthropic funding and partnerships under the new nonprofit structure.
Growing the user base to 100 million to achieve the scale needed for significant breakthroughs in understanding human health.

Key Themes

Research Findings12

23andMe has the first FDA-approved direct-to-consumer genetic test.

At its peak, 23andMe's market capitalization reached $5.7 billion.

Ann Wojcicki acquired 23andMe for $305 million in cash following its bankruptcy.

After acquiring the company, Ann Wojcicki restructured 23andMe as a nonprofit organization.

Hackers accessed data from 6.9 million 23andMe user profiles.

23andMe filed for bankruptcy on March 23, 2025.

Ann Wojcicki resigned as CEO of 23andMe in order to be eligible to participate in the bidding process during the company's Chapter 11 bankruptcy filing.

The entire board of 23andMe, including investors Roelof Botha and Patrick Chung, and YouTube CEO Neal Mohan, resigned simultaneously in 2024.

The resigning board of 23andMe issued a statement citing a lack of a "fully financed, fully diligenced, actionable proposal" and differences in strategic direction.

Ann Wojcicki states the 23andMe security incident was a credential stuffing attack affecting 13,000 to 14,000 accounts, not a direct breach of its systems.

Drugmaker Regeneron was the initial winner in the bankruptcy auction for 23andMe's assets before Ann Wojcicki successfully petitioned the court to reopen the case.

Regeneron ultimately declined to submit a final bid for 23andMe's assets, allowing Ann Wojcicki's offer to win.

Topics

23andMe Ann Wojcicki Genetics Biotechnology Healthcare Tech Direct-to-Consumer (DTC)Bankruptcy Corporate Restructuring Nonprofit Model Data Breach Credential Stuffing Data Privacy Founder Story Susan Wojcicki Silicon Valley

Processed Jun 29, 2026Daily intelligence brief → yt-dlp + mlx-whisper + Gemini

The Rise, Bankruptcy and Rebirth of 23andMe | The Circuit

Continue your research

Concerns Raised

Opportunities Identified

Key Themes

The Rise and Fall of a Biotech Darling

Founder's Resilience and Comeback

Pivoting to a Mission-Driven Nonprofit

The Promise and Peril of Genetic Data

Research Findings12

Topics